Effect of Mat Pilates Training on Women After Menopause

Effect of Mat Pilates Training on Climacteric Symptoms and Physiological Changes in Women After Menopause

This project aims to verify the chronic effect of Mat Pilates exercise on climacteric symptoms, ambulatory blood pressure responses, lipid and glucose profile and pro and anti-inflammatory and antioxidant markers in postmenopausal normotensive and hypertensive women. All volunteers received the same intervention.

Study Overview

• Status: Completed
• Conditions: Physical Activity; Blood Pressure
• Intervention / Treatment: Other: Hypertensive group; Other: Normotensive group

Detailed Description

The Pilates program was performed three times a week for 12 weeks. Initially a familiarization was made regarding the principles of the method. All volunteers underwent 24-hour blood pressure assessment using ambulatory blood pressure measurement (ABPM) and venous blood samples were collected from fasting, saliva and questionnaires before and after the Pilates training period.

• Study Type: Interventional
• Enrollment (Actual): 50
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Brazil
  • Minas Gerais
    • Uberlândia, Minas Gerais, Brazil, 38400-678
      • Jaqueline Pontes Batista

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 40 years to 70 years (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: Female

Description

Inclusion Criteria:

• Women between the ages of 40 and 70;
• Be post menopausal (amenorrhea for at least 12 months);
• Medical release to perform physical activities.
• Do not present physical problems or cardiovascular complications that prevent the performance of physical exercises;

Exclusion Criteria:

• To present a history of stroke or acute myocardial infarction;
• Smoking;
• Diagnosis of Diabetes Mellitus.
• Present renal pathologies.
• Use medications that interfere with lipid metabolism;
• Use of antihypertensive drugs (except for the hypertensive group);
• Use hormone replacement therapies;
• Present gastrointestinal conditions.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Non-Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Other: Hypertensive group; The Mat Pilates session was held lasting 50 minutes of exercises with the first 5 minutes heating and in each exercise performing 10 repetitions with 45 seconds of rest between one exercise and another. For practice, are used only mats, and alternative devices such as the Swiss ball and the flexible ring, as well as body weight and the force of gravity as resistance factors and Borg's subjective perception of effort scale for intensity parameters. The 20 exercises were chosen through the classic exercises thus classified by the creator of the Joseph Pilates method.During the sessions, volunteers were instructed on correct breathing without performing the valsalva maneuver.	Other: Hypertensive group; Pilates 12-week training on the ground, often 3 times a week for 50 minutes of prescribed method exercises.
Other: Normotensive group; The Mat Pilates session was held lasting 50 minutes of exercises with the first 5 minutes heating and in each exercise performing 10 repetitions with 45 seconds of rest between one exercise and another. For practice, are used only mats, and alternative devices such as the Swiss ball and the flexible ring, as well as body weight and the force of gravity as resistance factors and Borg's subjective perception of effort scale for intensity parameters. The 20 exercises were chosen through the classic exercises thus classified by the creator of the Joseph Pilates method.During the sessions, volunteers were instructed on correct breathing without performing the valsalva maneuver.	Other: Normotensive group; Pilates 12-week training on the ground, often 3 times a week for 50 minutes of prescribed method exercises.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Blood pressure	Resting diastolic and systolic blood pressures will be monitored by Microlife® BP 3BT0A automatic monitor in mmHg.	Change from Baseline at 12 weeks

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Ambulatory blood pressure monitoring	Ambulatory blood pressure monitoring will be monitored during 24 hours using a Dyna+ ABPM device in mmHg.	Change from Baseline at 12 weeks
Kupperman - Blatt Index	The climacteric symptoms will be evaluated by the following questionnaire Kupperman - Blatt Index. The questionnaire has scores that from 0 to 19 indicate mild symptoms, 20 to 35 moderate and greater than 35 symptoms of severe climacteric.	Change from Baseline at 12 weeks
Cervical Scale	The climacteric symptoms will be evaluated by the following questionnaire Cervical Scale. The questionnaire does not have scales. Indicates only a high or low score regarding the presence of climacteric symptoms.	Change from Baseline at 12 weeks
Menopause Rating Scale (MRS)	The climacteric symptoms will be evaluated by the following questionnaire Menopause Rating Scale (MRS). The scores from 0 to 4 of the questionnaire indicate absence of symptoms, as well as from 5 to 8 presence of mild symptoms, 9 to 15 moderate and greater than 16 symptoms of severe climacteric.	Change from Baseline at 12 weeks
Sleep quality	Sleep quality will be assessed by the Pittsburgh Sleep Quality Index (PSQI).A score of 0 to 4 indicates a good quality of sleep, 5 to 10 quality of bad sleep and greater than 10 the presence of sleep disorder.	Change from Baseline at 12 weeks

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
Biochemical analyzes	From the serum and/or plasma and saliva samples collected and stored, analyzes for lipid profile (total cholesterol and fractions, and triglycerides) and glycemia at rest and for the concentrations of inflammatory cytokines and changes in the activity of the Antioxidant system.	Change from Baseline at 12 weeks

Collaborators and Investigators

• Sponsor: Federal University of Uberlandia
• Investigators: Study Director: Guilherme M Puga, Phd, Federal University of Uberlândia

Study record dates

Study Major Dates

• Study Start (Actual): August 5, 2017
• Primary Completion (Actual): December 20, 2017
• Study Completion (Actual): March 28, 2018

Study Registration Dates

• First Submitted: April 24, 2017
• First Submitted That Met QC Criteria: August 9, 2018
• First Posted (Actual): August 13, 2018

Study Record Updates

• Last Update Posted (Actual): March 22, 2022
• Last Update Submitted That Met QC Criteria: March 7, 2022
• Last Verified: March 1, 2022

More Information

Terms related to this study

• Keywords: Blood Pressure; Pilates; Postmenopausal women
• Other Study ID Numbers: 68408116.9.0000.5152

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No